MLYS vs NVR · $2.17B cap vs P/E 15, rev $4.21B
Mineralys Therapeutics, Inc. Common Stock (MLYS) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Mineralys Therapeutics, Inc. Common Stock (MLYS) is a biotechnology company listed on US.
NVR Inc (NVR) is a residential construction company listed on NYSE.
MLYS does not have a complete income-statement cache yet.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
MLYS currently screens at market cap $2.17B. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the MLYS and NVR stock pages for the full models.
Not investment advice.